Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2005044237) PHARMACEUTICAL COMPOSITION HAVING A CATIONIC EXCIPIENT
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2005/044237 International Application No.: PCT/SE2004/001569
Publication Date: 19.05.2005 International Filing Date: 29.10.2004
IPC:
A61K 9/10 (2006.01) ,A61K 47/18 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
16
containing nitrogen
18
Amines; Quaternary ammonium compounds
Applicants:
CAMURUS AB [SE/SE]; Jägerhillsgatan 15 S-213 75 Malmö, SE (AllExceptUS)
LJUSBERG-WAHRÉN, Helena [SE/SE]; SE (UsOnly)
LUNDBERG, Dan [SE/SE]; SE (UsOnly)
HOLMBERG, Krister [SE/SE]; SE (UsOnly)
Inventors:
LJUSBERG-WAHRÉN, Helena; SE
LUNDBERG, Dan; SE
HOLMBERG, Krister; SE
Agent:
AWAPATENT AB; Box 45086 S-104 30 Stockholm, SE
Priority Data:
0302924-605.11.2003SE
Title (EN) PHARMACEUTICAL COMPOSITION HAVING A CATIONIC EXCIPIENT
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT UN EXCIPIENT CATIONIQUE
Abstract:
(EN) The invention relates to a pharmaceutical composition comprising a pharmaceutically effective amount of a pharmaceutically active substance and a pharmaceutically acceptable carrier comprising a cationic excipient, wherein said cationic excipient is a labile ester of betaine and a lipophilic alcohol having at least one primary hydroxyl group. The invention also relates to the use of a labile ester of betaine and a lipophilic alcohol having at least a primary hydroxyl group as a cationic excipient in a carrier for a pharmaceutical composition comprising a pharmaceutically active substance.
(FR) La présente invention concerne une composition pharmaceutique contenant une quantité pharmaceutiquement acceptable d'une substance présentant une activité pharmacologique et un excipient pharmaceutiquement acceptable comprenant un excipient cationique. L'excipient cationique est un ester de bétaïne labile et un alcool lipophile présentant au moins un groupe hydroxyle primaire. Cette invention concerne également l'utilisation d'un ester de bétaïne labile et d'un alcool lipophile présentant au moins un groupe hydroxyle primaire en tant qu'excipient cationique dans un porteur pour une composition pharmaceutique contenant une substance présentant une activité pharmacologique.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP1684730US20070031485